<html>
<head>
<title>Section 126-Q:1 Definitions.</title>
<!-- Hide metadata
<titlename>TITLE X PUBLIC HEALTH</titlename>
<chapter>CHAPTER 126-Q NEW HAMPSHIRE VACCINE ASSOCIATION</chapter>
<sectiontitle>Section 126-Q:1 Definitions.</sectiontitle>
-->
</head>
<body>
<center><h1>TITLE X<br>PUBLIC HEALTH</h1></center>
<center><h2>CHAPTER 126-Q<br>NEW HAMPSHIRE VACCINE ASSOCIATION</h2></center>
<center><h3>Section 126-Q:1</h3></center>
&nbsp;&nbsp;&nbsp;<b> 126-Q:1 Definitions. &#150;</b>
<codesect>
In this chapter:
<br>
&nbsp&nbsp&nbsp
I. "Association'' means the New Hampshire vaccine association.
<br>
&nbsp&nbsp&nbsp
II. "Commissioner'' means the commissioner of the department of health and human services.
<br>
&nbsp&nbsp&nbsp
III. "Covered lives'' shall have the same meaning as defined in RSA 404-G:2, V.
<br>
&nbsp&nbsp&nbsp
IV. "Estimated vaccine cost'' means the estimated cost to the state over the course of a state fiscal year of the purchase, distribution, and administration of vaccines purchased at the federal discount rate by the department of health and human services.
<br>
&nbsp&nbsp&nbsp
V. "Health insurance'' shall have the same meaning as defined in RSA 404-G:2, VII.
<br>
&nbsp&nbsp&nbsp
VI. [Repealed.]
<br>
&nbsp&nbsp&nbsp
VII. "Total non-federal program cost'' means the estimated vaccine cost less the amount of federal revenue available to the state for the purchase, distribution, and administration of vaccines.
<br>
&nbsp&nbsp&nbsp
VIII. "Vaccine'' means any preparations of killed microorganisms, living attenuated organisms, or living fully virulent organisms that are approved by the federal Food and Drug Administration and recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention and have been authorized by the commissioner of the department of health and human services for administration to children of the state of New Hampshire under the age of 19 years for the purposes of producing or artificially increasing immunity to particular life-threatening and disabling diseases.
</codesect>
<sourcenote>
<p><b>Source.</b>  2002, 279:2, eff. June 17, 2002.  2008, 375:17, eff. July 1, 2008.</p>
</sourcenote>
</body>
</html>
